{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:59:43Z","timestamp":1761170383701,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer-Ingelheim"},{"name":"Galenica"},{"name":"Elpen"},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Winmedica"},{"name":"BMS\/Pfizer"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abbot Vascular"},{"DOI":"10.13039\/501100003103","name":"ASTRA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003103","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer-Ingelheim"},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer-Ingelheim"},{"name":"Elpen"},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer-Ingelheim"},{"DOI":"10.13039\/501100003103","name":"ASTRA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abbot Vascular"},{"name":"Gore"},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer-Ingelheim"},{"name":"Elpen"},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer-Ingelheim"},{"name":"Elpen"},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Menarini"},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Menarini"},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer Ing"},{"name":"Elpen"},{"name":"Winwedica"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mylan"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.hjc.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T12:04:33Z","timestamp":1583150673000},"page":"435-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Expert consensus statement for the management of patients with embolic stroke of undetermined source and patent foramen ovale: A clinical guide by the working group for stroke of the Hellenic Society of Cardiology and the Hellenic Stroke Organization"],"prefix":"10.1016","volume":"61","author":[{"given":"Georgios","family":"Ntaios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Tzikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Vavouranakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Nikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Katsimagklis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Koroboki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonis S.","family":"Manolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haralampos","family":"Milionis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skevos","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Spengos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Toutouzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Tziakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Vassilopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Kanakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Vemmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2020.02.001_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hjc.2020.02.001_bib2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2020.02.001_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(88)92944-3","article-title":"Patent foramen ovale in young stroke patients","volume":"2","author":"Webster","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2020.02.001_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jama.299.5.521","article-title":"Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004","volume":"299","author":"Opotowsky","year":"2008","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.hjc.2020.02.001_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2013.08.058","article-title":"Pfo closure vs. Medical therapy in cryptogenic stroke or transient ischemic attack: A systematic review and meta-analysis","volume":"169","author":"Ntaios","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hjc.2020.02.001_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","article-title":"Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: Updated systematic review and meta-analysis","volume":"49","author":"Ntaios","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.hjc.2020.02.001_bib7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2020.02.001_bib8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2020.02.001_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2020.02.001_bib10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. Antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2020.02.001_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or\u00a0antiplatelet\u00a0therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2020.02.001_bib12","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: The defense-pfo trial","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2020.02.001_bib13","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.117.030509","article-title":"Embolic stroke","volume":"136","author":"Ntaios","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2020.02.001_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: The case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hjc.2020.02.001_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012858","article-title":"Prevalence and overlap of potential embolic sources in patients with embolic stroke of undetermined source","volume":"8","author":"Ntaios","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hjc.2020.02.001_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.hjc.2020.02.001_bib17","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent\u00a0foramen ovale and embolic stroke of undetermined source: A prespecified subgroup\u00a0analysis from the navigate esus trial","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hjc.2020.02.001_bib18","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2020.02.001_bib19","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2020.02.001_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1474-4422(17)30002-9","article-title":"Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (find-afrandomised): An open-label randomised controlled trial","volume":"16","author":"Wachter","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hjc.2020.02.001_bib21","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.117.028845","article-title":"Subclinical atrial fibrillation in older patients","volume":"136","author":"Healey","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2020.02.001_bib22","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.08.015","article-title":"Embolic stroke of undetermined source and detection of atrial fibrillation on follow-up: How much causality is there?","volume":"25","author":"Ntaios","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.hjc.2020.02.001_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejim.2018.02.019","article-title":"Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices","volume":"52","author":"Miyazawa","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hjc.2020.02.001_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0000000000002282","article-title":"Predictors for atrial fibrillation detection after cryptogenic stroke: Results from crystal af","volume":"86","author":"Thijs","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.hjc.2020.02.001_bib25","doi-asserted-by":"crossref","first-page":"e2644","DOI":"10.1212\/WNL.0000000000007611","article-title":"Carotid plaques and detection of atrial fibrillation in embolic stroke of undetermined source","volume":"92","author":"Ntaios","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.hjc.2020.02.001_bib26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4244\/EIJ-D-18-00622","article-title":"European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism","volume":"14","author":"Pristipino","year":"2019","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.hjc.2020.02.001_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jacc.2005.11.024","article-title":"Patent foramen ovale, guilty but only as a gang member and for a lesser crime","volume":"47","author":"Meier","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2020.02.001_bib28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcin.2018.11.001","article-title":"Antithrombotic therapy and device-related thrombosis following endovascular left atrial appendage closure","volume":"12","author":"Saw","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hjc.2020.02.001_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11910-018-0910-y","article-title":"Closure of patent foramen ovale and cryptogenic stroke: Unresolved issues","volume":"18","author":"Diener","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.hjc.2020.02.001_bib30","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.amjcard.2019.01.043","article-title":"Impact of discontinuation of antithrombotic therapy following closure of patent foramen ovale in patients with cryptogenic embolism","volume":"123","author":"Wintzer-Wehekind","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hjc.2020.02.001_bib31","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect\u00a0of medical treatment in stroke patients with patent foramen ovale: Patent\u00a0foramen ovale in cryptogenic stroke study","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2020.02.001_bib32","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","article-title":"Anticoagulant vs. Antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: An individual participant data meta-analysis","volume":"36","author":"Kent","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2020.02.001_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/STROKEAHA.111.631648","article-title":"Patent foramen ovale closure and medical treatments for secondary stroke prevention: A systematic review of observational and randomized evidence","volume":"43","author":"Kitsios","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.hjc.2020.02.001_bib34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: A prespecified subgroup analysis from the navigate esus trial","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hjc.2020.02.001_bib35","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1161\/STROKEAHA.119.026512","article-title":"Antithrombotic treatment in cryptogenic stroke patients with patent foramen ovale: Systematic review and meta-analysis","volume":"50","author":"Sagris","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.hjc.2020.02.001_bib36","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1080\/14656566.2018.1515913","article-title":"Non-vitamin-k oral anticoagulants (noacs) for the prevention of secondary stroke","volume":"19","author":"Diener","year":"2018","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.hjc.2020.02.001_bib37","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1161\/STROKEAHA.117.017549","article-title":"Real-world setting comparison of nonvitamin-k antagonist oral anticoagulants versus vitamin-k antagonists for stroke prevention in atrial fibrillation: A systematic review and meta-analysis","volume":"48","author":"Ntaios","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.hjc.2020.02.001_bib38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/1747493017700663","article-title":"Nonvitamin-k-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Ntaios","year":"2017","journal-title":"Int J Stroke"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966620300324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966620300324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:14:17Z","timestamp":1761099257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966620300324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1109966620300324"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2020.02.001","relation":{},"ISSN":["1109-9666"],"issn-type":[{"type":"print","value":"1109-9666"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert consensus statement for the management of patients with embolic stroke of undetermined source and patent foramen ovale: A clinical guide by the working group for stroke of the Hellenic Society of Cardiology and the Hellenic Stroke Organization","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}